Please note: The information displayed on this page might be outdated.
Paradigm BioPharma: Launching Ph 3 in 2020 in OA pts w/bone marrow edema lesions (BML). Positive Ph2b results in subjects w/OA & BML - stat sig improvement on pain reduction & BML volume/grade reductions on MRI. Q12020: initial data from compassionate use trial (ex-NFL subjects w/OA) and joint IND submission to FDA/EMA for pivotal trial in Mucopolysaccharidosis. 500+ pts treated to date. Exp AUS rev-gen in Q3 20.
Based in...
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Public, USA
Market Cap
500MM - 1B
517 Finders Lane
Melbourne, VIC 3000

Company Participants at Solebury Trout Virtual Global Healthcare Conference Series

  • Paul Rennie, Chief Executive Officer

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Paradigm Biopharmaceuticals Ltd.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RBC Global Asset Management (Asia) Ltd. 2.20 4,220,259 10.09 Funds 2020-05-29
The Vanguard Group, Inc. 2.09 4,014,634 9.59 Funds 2020-05-31
Perennial Value Management Ltd. 0.64 1,437,500 3.44 Stakes 2019-08-21
Vanguard Investments Australia Ltd. 0.24 461,475 1.10 Funds 2020-04-30
Smith & Williamson Investment Management LLP 0.09 180,000 0.43 Funds 2020-05-29
RAM Active Investments SA 0.09 164,866 0.39 Funds 2019-12-31
Adepa Asset Management SA 0.06 115,000 0.27 Funds 2019-12-31
State Street Global Advisors, Australia, Ltd. 0.00 0 0.00 Funds 2020-07-03
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.